The symptoms of this dysfunction are everywhere, from the American hedge fund manager who dramatically increased the cost of an AIDS treatment to the children's cancer medications purposefully placed in a Spanish warehouse to expire. To maximise profits, a system that was designed to promote innovation and enhance patient care has been skewed. In Sick Money, the investigative reporter who revealed a billion-pound British price-hiking scam delves into the global struggle against exorbitant medicine costs. Billy Kenber demonstrates how drugs have devolved into little more than financial assets, from shadowy dealings to patients being compelled to use the underground market. He presents a diagnostic of an industry in crisis and a treatment plan for its recovery.